Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025

The second quarter edition of the Superpowers for Good Live Pitch concluded with Siren Biotechnology and RISE Robotics being recognized for their groundbreaking work. Dr. Nicole Paulk, CEO of Siren Biotechnology, received the SuperCrowd Award, chosen by the global livestream audience for her company’s novel cancer treatments. Meanwhile, Hiten Sonpal, CEO of RISE Robotics, was awarded the Judges’ Choice Award for his company’s innovative approach to making industrial motion systems more energy-efficient.

Devin Thorpe, founder of The Super Crowd, Inc., praised both winners for embodying the event’s spirit. Siren Biotechnology’s work in developing targeted, less toxic cancer therapies and RISE Robotics’ solution to replace inefficient hydraulic systems in heavy machinery were highlighted as exemplary of innovation with significant social impact.

The event, streamed live on multiple platforms, showcased four founders presenting their Regulation Crowdfunding campaigns. The winners received a comprehensive prize package aimed at supporting their growth, including marketing strategy consultations, capital-raising advice, and tools for investor intelligence and compliance.

Thorpe emphasized the unique community aspect of the Superpowers for Good Live Pitch, where the audience actively participates by voting, asking questions, and investing. The event not only provides recognition but also tangible resources to help entrepreneurs advance their missions. The next live pitch is scheduled for late September 2025, continuing the tradition of spotlighting high-impact founders driving social good through entrepreneurship.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025.